LENSAR, Inc. - stock earnings
LNSR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -3.9 million USD | 12.1 million USD |
2023Q3 | 2.6 million USD | 9.8 million USD |
2023Q2 | -8.8 million USD | 12.0 million USD |
2023Q1 | -4.5 million USD | 8.3 million USD |
2022Q4 | -3.2 million USD | 10.2 million USD |
2022Q3 | -3.9 million USD | 7.7 million USD |
2022Q2 | -6.7 million USD | 8.0 million USD |
2022Q1 | -6.7 million USD | 9.3 million USD |
2021Q4 | -3.9 million USD | 11.2 million USD |
2021Q3 | -6.2 million USD | 8.3 million USD |
2021Q2 | -4.4 million USD | 7.9 million USD |
2021Q1 | -5.2 million USD | 7.0 million USD |
2020Q4 | -6.8 million USD | 8.3 million USD |
2020Q3 | -4.8 million USD | 7.1 million USD |
2020Q2 | -4.5 million USD | 5.0 million USD |
2020Q1 | -3.7 million USD | 5.9 million USD |
2019Q4 | -2.5 million USD | 8.5 million USD |
2019Q3 | -5.8 million USD | 8.1 million USD |
LNSR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -14.4 million USD | 42.2 million USD |
2022 | -19.7 million USD | 35.4 million USD |
2021 | -19.7 million USD | 34.5 million USD |
2020 | -21.2 million USD | 26.4 million USD |
2019 | -16.7 million USD | 30.5 million USD |
2018 | -12.6 million USD | 24.4 million USD |
LNSR
Price: $3.24
52 week price:
Earnings Per Share: -1.31 USD
P/E Ratio: -3.95
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 3193
Market Capitalization: 37.4 million